Alexander Ng

An absolute honour to win First Prize for Best Abstract by a Resident #eau23 @PrimeMRI With thanks to all my supervisors and mentors @veerukasi @giga_fra @BURSTurology, friends and family. #UroSoMe @Uroweb @EAUrf @eau_yuo @ESRUrology @EAUYAUrology

⭐ Thrilled to see @COMPASSurology research cited in the #EAU26 PCa Guidelines! 📍 GLIMPSE (@radiology_rsna): Highlighting the global variation and feasibility of quality improvement 📍 PRIME (@JAMA_current): Confirming non-inferiority of bpMRI to mpMRI for csPCa detection

Great discussions at the #ARTS Trial Lunch Meeting during #EAU26 🌍 Investigators from centres across the world came together to discuss the updated protocol, trial progress, and the role of apixaban in peri-operative #thromboprophylaxis - watch this space! 👀 Fantastic to see the global collaboration behind #ARTS 👉 also a look at ClueVTE.org, the evidence-based VTE risk calculator developed by the #CLUE group 🧠 Thrilled to see the progress being made worldwide for #ARTS, and proud for @BURSTurology to support international collaborative #research #UroSoMe

🇵🇹 Fantastic to hear from @EFelicio93 sharing the realities of setting up #WASHOUT in Portugal at our BURST session at #EAU26 From the paperwork to navigating ethics, GDPR, and data entry barriers, this is the reality of delivering international #research ‼️ Eduardo has been one of our top contributors to #WASHOUT and we genuinely could not do this without collaborators like him across the network 📍 Still time to join us in Connaught 1 NOW! #UroSoMe #EAU26

🚨 Happening now at #EAU26 🚨 The BURST Collaborative Session is LIVE in 📍 Connaught 1 (13:00-15:00) discussing all things #WASHOUT 🩸 We are sharing 👀 interim results exploring how we investigate and manage haematuria across centres worldwide Still time to join us for the discussion and see what the early data are telling us 👇

Look forward to catching up with you @ #EAU26 🇬🇧 @Uroweb. This year the journey is easier but the goal will be the same: top science, great collaborations & catching up with friends. Be there or be square. Bring your coats 🥶 @BURSTurology @COMPASSurology @ucl @clecliniclondon

Absolute honour to win the @myESR #ECR2026 Genitourinary Best Research Presentation Abstract Award on behalf of the #PRIME Team 🏆 Ranks top 14/11,376 submissions (0.1%) (one award per category). A testament to years of dedication from @COMPASSurology and our global partners 🌍

1/ 📢 PUBLICATION ALERT! #RESECT is one of @BURSTurology’s most ambitious studies, with a novel #trial design - a cluster RCT with 200+ sites with 15000+ patients, now in @EUplatinum ⚡ Can private, personal feedback and education about endoscopic surgery (TURBT) change surgeon behaviour and improve outcomes in bladder cancer? 🤔 Read HERE: doi.org/10.1016/j.euru…

Get involved in our next trial 👇 #PARADIGM @veerukasi @AlexBCDNg @COMPASSurology #UroSoMe

Day 4 @myESR #ECR2026 Delighted to see interest in @COMPASSurology upcoming trial #PARADIGM - international multicentre prospective trial of AI vs Radiologist for PCa detection Interested in taking part? Now is the time so submit an expression of interest before it's too late!

Very proud of @AlexBCDNg @AquaAsif for winning the #ECR2026 Prize for one of the best oral abstracts of the meeting out of more than 11,000 submissions for the #PRIME study lesion level and secondary definition results. #bpMRI new SOC. jamanetwork.com/journals/jama/…

Multiple high level talks @ #ECR2026 showing biparametric MRI as good as multiparametric MRI 4 prostate cancer detection. Not just in diagnostic setting - also in active surveillance & with less experienced readers, providing image quality good. Strong call for changing SOC

Day 3 @myESR #ECR2026 @veerukasi asking thought provoking questions on synthetic data in genAI Prostate MRI scoring systems session by @voxelmator @Tristan_Radiol Maarten de Rooij @GiorgioBre @veerukasi covering PRECISE, PI-QUAL, PI-RR, PI-FAB, TARGET and Uro perspective

Day 2 @myESR #ECR2026 highlight: delivering #PRIME oral on lesion level & GG≥3 analysis 🚨 bpMRI consistently non-inferior to mpMRI for GG1, ≥2, ≥3 (patient and lesion-level)  🏆 Prize winner! Keep👀 peeled for Sat! 👏 Thanks Raphaele Renard-Penna for chairing!

Day 1 @myESR #ECR2026 key takeaways on #ProstateMRI & #AI from @Purysko, Sotirios Bisdas & Jorge Soto Great to see @COMPASSurology trials highlighted! Useful insights for my PhD and a new #PARADIGM. Watch this space!

Super excited for #ECR2026 tomorrow!

🚨 JUST PUBLISHED in @EUplatinum Updated meta-analysis (40 studies, 9,400+ patients) shows #bpMRI is NONINFERIOR to #mpMRI for clinically significant #PCa 🌟 First to include #PRIME trial data; proud to be part of this 🌏 collaboration 📄 Read HERE: sciencedirect.com/science/articl…

💡bpMRI vs mpMRI. Meta-analysis now out in @EUplatinum. Huge team effort. Especially proud of @redeirtsg. @StephanAltmayer, Torri, Prediger, @JORGEANDRESABR2, @SangeetGhai, @radfiler, Ghezzi, Andrade, @A_PonsiglioneMD, @GiorgioBre, @giga_fra, @AquaAsif, @AlexBCDNg, @veerukasi

Exciting news to start the year 🎉 Delighted to welcome our new Co-Vice Chairs @AquaAsif, @AlexBCDNg & @dr_steph_smith With ⏫ thanks to @CamEAlexander & @StefanieCroghan for their brilliant leadership. Big shoes to fill. Plenty ahead for BURST Watch this space 👀 #UroSoMe

Congratulations to Dr Veeru Kasivisvanathan who has been awarded the prestigious Society of Apothecaries’ @ApothecariesLDN2026 William Farr Medal in recognition of his research advancing prostate cancer care globally ucl.ac.uk/news/2026/jan/…

RESECT: A Randomised Controlled Trial of Audit and Feedback in Non–muscle-invasive Bladder Cancer Surgery buff.ly/MwfEviw Cluster randomised controlled trial evaluated whether audit, feedback, peer comparison, and education improved surgical performance after transurethral resection of bladder tumour for non–muscle-invasive #BladderCancer . Across 201 sites and 14,915 patients, the intervention significantly improved documentation of tumour features and resection completeness but did not increase detrusor muscle sampling, single-instillation chemotherapy use, or reduce early recurrence. Improvements in the control arm may have attenuated intervention effects on clinical outcomes. @kmj_gallagher @5tevenMacLennan @NikitaB0709 @keirandavid @efzimmermann @mrSinanK @AquaAsif @AJWLight @AlexBCDNg @VinsonChan @ArjunSNathan @muratakand06 @pietropiazza @gautiermarcq @tsoburol @m_e_nielsen @f_delgiudice @luca_orecchia @DabenDawam @DrAlbert @drmostafa961 @JackFanshawe2 @hjwang26 @Dr_RPM @Conor_McCann_91 @JGomezRivas @ElhadiMuhammed @srossi725 @jteoh_hk @ParamMariappan @veerukasi